Vivus says activist investor criticisms are off base

(Reuters) – Obesity drugmaker Vivus Inc on Tuesday said its biggest investor, First Manhattan Co, has been offering only “uncertainty and delay” in its efforts to shake up the company’s board of directors.

Powered by WPeMatico

This entry was posted in World News. Bookmark the permalink.

Comments are closed.